AJP - Regu  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 278: R556-R562, 2000;
0363-6119/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, K. P.
Right arrow Articles by Carmines, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, K. P.
Right arrow Articles by Carmines, P. K.
Vol. 278, Issue 3, R556-R562, March 2000

Norepinephrine turnover in peripheral tissues of rats with heart failure

Kaushik P. Patel, Kun Zhang, and Pamela K. Carmines

Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska 68198-4545


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Experiments were performed to determine if there is regional heterogeneity in sympathetic neural activation of peripheral tissues in rats with chronic heart failure (HF; 6-8 wk after coronary artery ligation). Norepinephrine (NE) turnover, an index of sympathetic activation, was determined on the basis of the decline in tissue NE levels that occurs during the 8-h after tyrosine hydroxylase inhibition (alpha -methyl-DL-p-tyrosine, 300 mg/kg ip at 4-h intervals). Compared with sham-operated rats, NE turnover was increased in the cardiac left ventricle, skeletal muscle, duodenum, and kidney of rats with HF, but was unaltered in liver and spleen. The increased renal NE turnover in HF was largely a reflection of increased turnover in the cortex, with no change evident in the medulla. Blockade of sympathetic ganglionic traffic (hexamethonium, 2 mg/kg sc at 2-h intervals) eliminated the tissue-specific effects of HF on tissue NE levels measured 8-h after tyrosine hydroxylase inhibition. These data support the contention that chronic HF evokes a central nervous system-mediated increase in basal sympathetic tone that exhibits regional heterogeneity (both between and within organs), a phenomenon that likely contributes to the functional consequences of this pathophysiological state.

myocardial infarction; sympathetic activation; renal nerve activity


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

CONGESTIVE HEART FAILURE (HF) activates a variety of neurohumoral systems, including the sympathetic nervous system, renin-angiotensin-aldosterone system, and pituitary vasopressin system. Numerous experimental approaches have been employed in attempts to clarify the pathophysiological role of sympathetic nervous system activation in HF, which is implied by elevated plasma catecholamine levels in HF patients (8, 22). Plasma norepinephrine concentration ([NE]) represents the balance between spillover of NE into plasma and the clearance of NE from plasma. These events, in turn, are dependent on various processes that include the release, reuptake, and breakdown of NE by the myriad tissues of the body (14). Hence, the interactive and dynamic nature of the determinants of plasma [NE] limits the utility of this parameter as an indicator of sympathetic nervous system activity. Targeted assessments of the nature and extent of sympathetic activation in clinical HF have employed microneurographic monitoring of muscle sympathetic nerve traffic (16, 28) and quantitative assessment of sympathetic activity by radiotracer methodologies (13, 22, 38). The results of these investigations suggest that HF evokes a regional (rather than generalized) pattern of sympathetic activation in humans.

The opportunity to more fully address questions concerning the source and distribution of the elevated sympathetic drive in HF is provided through the use of experimental models, such as the coronary artery ligation model of HF in the rat. As in humans with HF, these animals display elevated plasma catecholamine levels (27, 33). Moreover, renal sympathetic nerve activity measured by multifiber recordings appears to be elevated relative to normal rats (10, 15, 27), suggesting that increased central sympathetic outflow accompanies HF. However, the validity of quantitative comparisons between groups using this technique remains uncertain, because measurement of integrated voltage from a multifiber recording is dependent on the position of the electrode and the nerve preparation (23). It is also important to note that these animals had been subjected to surgery (to implant recording electrodes) only 6-8 h before measuring nerve activity and thus may have still been under some degree of postsurgical stress (10, 15).

NE turnover can be used as a useful indicator of noradrenergic function in specific tissues harvested from experimental animals (5, 31, 39); however, the effect of HF on this parameter has only been assessed in the heart and the results appear to vary between HF models. Specifically, cardiac NE turnover is increased in the cardiomyopathic hamster (41), unaltered or slightly increased in pressure overload hypertrophy (17), and increased in the failing heart of the diabetic rat (19). The literature contains no NE turnover data obtained simultaneously in multiple tissues of conscious rats with HF induced by coronary artery ligation, information that would expose the specific targets of sympathetic activation in the HF state. In addition to targeted sympathetic activation of specific organs, the intriguing possibility exists that HF may alter sympathetic outflow to different regions of individual organs such as the kidney, where independent regulation of cortical and medullary processes can have substantial hemodynamic and excretory consequences (11).

The purpose of the present study was to examine the hypothesis that experimental HF provokes a centrally mediated, regionally heterogeneous increase in sympathetic tone. To address this hypothesis, basal sympathetic tone in a variety of peripheral tissues (as well as in different regions of the kidney) was assessed by measurement of NE turnover in conscious rats studied 6-8 wk after coronary artery ligation (or sham surgery). This model represents the most common mechanical cause of HF seen clinically, and the time course for development of HF mimics the clinical situation (18, 36). In additional experiments, ganglionic blockade was employed to assess the contribution of central nervous system-mediated events to the alterations in NE turnover that were evident during HF.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animals. Experiments were conducted in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" after approval was received by the University of Nebraska Medical Center Institutional Animal Care and Use Committee. Male Sprague-Dawley rats weighing 250-280 g were purchased from Sasco Breeding Laboratories (Omaha, NE). The rats were assigned randomly to one of two groups: HF and sham operated. The method of producing HF was similar to that previously described (18, 36). Briefly, each rat was anesthetized with pentobarbital sodium (50 mg/kg ip), and the trachea was cannulated to facilitate ventilation. A left thoracotomy was performed, and the heart was gently lifted out of the thorax. In the HF rats, the left coronary artery was ligated between the pulmonary artery outflow tract and left atrium as it exits the aorta. Sham-operated rats underwent thoracotomy and manipulation of the heart, but the coronary artery was not ligated. After these maneuvers were completed, the heart was returned to its original position and the thorax was closed. The air within the thorax was removed, allowing the rats to resume spontaneous respiration. The trachea was sutured, the neck incision was closed, and the rats were allowed to recover from the anesthesia. The rats were caged individually thereafter, receiving analgesics (Nubain-Stadol, 1 ml/kg sc) on each of the first 2 days after surgery. The animal quarters had a 12:12-h light-dark cycle with ambient temperature maintained at 22°C and humidity at 30-40%. Laboratory chow (Purina) and tap water were available ad libitum. Six to eight weeks after surgery, the rats were used to measure turnover of NE.

NE turnover. Turnover of NE was calculated on the basis of the disappearance rate of NE after tyrosine hydroxylase inhibition (5). All rats were kept in their home cages during the NE turnover study. Animals in each group (sham operated and HF) were randomly assigned to three subgroups. Rats in the first subgroup were used to establish baseline tissue NE concentrations ([NE]0). These animals were killed by decapitation at time 0. The second subgroup received the tyrosine hydroxylase inhibitor alpha -methyl-DL-p-tyrosine methyl ester HCl (AMPT, 300 mg/kg ip; Sigma Chemical, St. Louis, MO) at time 0 and were killed 4 h later. The third subgroup received AMPT at both time 0 and time 4 h and were killed at time 8 h. The following tissues were harvested from each animal immediately after death: the noninfarcted apical region of the cardiac left ventricle, the entire left kidney, separate samples of cortex and outer medulla from the right kidney, a 2-cm length of duodenum, and representative samples of hindlimb skeletal muscle, spleen, and liver. These samples were weighed, homogenized in cold perchloric acid containing EDTA, and centrifuged at 4°C for 15 min at 15,000 g. The supernatants were stored at -70°C until they were assayed for catecholamines. [NE] were assayed using alumina extraction followed by separation and analysis with HPLC and electrochemical detection (Bioanalytical Systems, West Lafayette, IN). Dihydroxybenzylamine (Sigma) was used as an internal standard in each tissue sample. Details and validation of these procedures in our laboratory have been published previously (31).

Effect of ganglionic blockade. Additional experiments were performed to assess more directly the involvement of centrally mediated neural activation in eliciting the changes in NE efflux from peripheral tissues observed in animals with HF. Animals from each group (sham operated and HF) received injections of both AMPT (300 mg/kg ip) and hexamethonium bromide (2 mg/kg sc; Sigma) at time 0. AMPT treatment was repeated at 4-h intervals, whereas hexamethonium treatment was repeated at 2-h intervals. The animals were killed at time 8 h, after which tissues were harvested and processed for measurement of [NE] as detailed above. The data obtained from these animals were assumed to reflect tissue NE processing in the absence of sympathetic neural input (31).

Myocardial histology. Hearts from sham-operated and HF rats were sectioned into three major segments located from the atrium to the apex: A, B, and C. Segment C was used for NE turnover measurement, as detailed above. Segment B (representing the bulk of the left ventricle) was subjected to graded dehydration with ethanol, embedded in paraffin, cut into sequential 10-µm-thick sections, and stained with hematoxylin-eosin. Sections were projected onto a screen, and the outline of the tissue was diagrammed. The scale drawing thus obtained was used for measuring left ventricular outer (epicardial) and inner (endocardial) circumferences as well as the arc length of the infarcted region. The infarcted fraction of the left ventricular wall was calculated on the basis of these measurements.

Data analysis. Linear regression analysis of the log[NE] vs. time relationship was performed using individual data points obtained at 0, 4, and 8 h after tyrosine hydroxylase inhibition. The slope (m) and standard error of the regression coefficient (SER) were computed by the least squares method. Between-group comparison of slopes was performed using a t-test for parallelism (20). The rate constant for NE disappearance (kNE; defined as m/0.434), NE turnover time (1/kNE), and NE turnover rate ([NE]0 × kNE) were calculated as described by Brodie et al. (5). A t-test was employed to compare tissue [NE] measured 8 h after AMPT in hexamethonium-treated sham-operated and HF groups. Unless otherwise noted, all data are reported as means ± SE. P values < 0.05 were considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Cardiac histology. After histological data were examined, rats in the HF group that exhibited infarcts involving <35% of inner ventricular circumference were discarded from the study. At the time of the NE turnover studies, the body weight of rats retained in the HF group (344 ± 13 g, n = 26) was similar to that of sham-operated rats (318 ± 8 g, n = 28). The HF rats displayed transmural infarcts of the left ventricle involving 42.7 ± 1.3% of the inner circumference and 33.5 ± 1.5% of the outer circumference. Sham-operated rats had no observable damage to the myocardium. The minimum ventricular thickness was significantly less in HF rats (0.50 ± 0.04 mm) than in sham-operated rats (1.38 ± 0.15 mm; P < 0.05), suggesting a reduction in myocardial volume in the HF group. Although hemodynamic function was not assessed in these animals (to avoid compromising the NE turnover measurements), we and others previously documented that rats with similar large-to-moderate myocardial infarcts exhibit left ventricular end diastolic pressures exceeding 20 mmHg (18, 34-36).

Turnover of NE. In most tissues, [NE]0 (baseline levels measured in the absence of tyrosine hydroxylase inhibition) was similar in sham-operated and HF rats (Table 1); however, renal [NE]0 was elevated significantly in HF rats. Figure 1 illustrates the decline in tissue [NE] during the 8-h after tyrosine hydroxylase blockade. After blockade of synthesis, [NE] in each tissue declined exponentially with time as evidenced by a linear decrease in log[NE] vs. time (correlation coefficient > 0.90). The slope of this relationship, indicating the rate of NE disappearance, was significantly greater in muscle tissues of HF rats (m ± SER: left ventricle 0.066 ± 0.019 h-1, skeletal muscle 0.059 ± 0.007 h-1) than in sham-operated rats (left ventricle 0.021 ± 0.006 h-1; skeletal muscle 0.027 ± 0.005 h-1). HF rats also displayed accelerated NE disappearance from the kidney, with the slope values averaging 0.033 ± 0.007 h-1 in sham-operated and 0.076 ± 0.010 h-1 in HF rats (P < 0.05). This effect was largely indicative of a change in cortical NE disappearance rate (sham 0.046 ± 0.010 h-1, HF 0.075 ± 0.009 h-1; P < 0.05), as medullary NE disappearance rate was not altered significantly (sham 0.048 ± 0.016 h-1, HF 0.062 ± 0.036 h-1). Sham-operated and HF groups did not differ with regard to slope values calculated for the intestine, liver, or spleen (Fig. 1). Table 2 summarizes the effect of HF on the fraction of total NE that disappears per unit time (the rate constant, kNE) and the total time required for dissipation of tissue NE (turnover time). By virtue of the impact of HF on the slope of the log[NE] vs. time relationship, kNE was elevated significantly in both cardiac and skeletal muscle, as well as in kidney (cortex, but not medulla). Rate constants for duodenum, liver, and spleen did not differ between groups.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effect of HF on basal NE concentration in peripheral tissues



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Disappearance of norepinephrine (NE) from peripheral tissues after tyrosine hydroxylase inhibition (time 0). open circle  with solid regression lines, data from sham-operated rats;  with dashed regression lines, data from heart failure (HF) rats. Values represent means ± SE (n = 18-21/group). [NE]0, initial NE concentration. * P < 0.05 vs. sham-operated [comparison of regression line slopes using a t-test for parallelism (20)].


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effect of HF on rate constant and turnover times of tissue NE

NE turnover rates for peripheral tissues in the two groups of rats are summarized in Fig. 2. Compared with sham-operated rats, NE turnover was significantly higher in left ventricle, skeletal muscle, whole kidney, and renal cortex of HF rats, consistent with the accelerated rate of NE disappearance from these tissues. Although there was no significant effect of HF on the slope of the log[NE] vs. time relationship in duodenum (Fig. 1), there was increased NE turnover. HF failed to alter NE turnover in the renal medulla, liver, or spleen.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   NE turnover in peripheral tissues of sham-operated and HF rats. A, muscle; B, kidney; C, visceral organs. Values represent means ± SE (n = 6-8/group). * P < 0.05 vs. sham operated.

Assessment of central component by ganglionic blockade. Figure 3 illustrates tissue [NE] (% of mean [NE]0) measured 8 h after inhibition of NE synthesis in rats subjected to ganglionic blockade. There were no significant differences between sham-operated and HF rats with regard to relative NE levels remaining in any tissue studied 8 h after inhibition of NE synthesis. Thus elimination of the neurally mediated central component of NE turnover by ganglionic blockade abrogated the effect of HF to promote the disappearance of NE from muscle and kidney. These data suggest that the tissue-specific impact of HF on NE turnover requires activation from the central nervous system.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Tissue NE levels 8 h after tyrosine hydroxylase inhibition in rats subjected to ganglionic blockade. Values represent means ± SE (n = 6 or 7/group). There was no significant difference between sham-operated and HF groups in any tissues examined.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The present study provides two principal new findings related to the status of the sympathetic nervous system in HF. First, conscious undisturbed rats with HF display tissue-specific increases in peripheral NE turnover, i.e., increases in some regions but not all. Second, ganglionic blockade abolishes the differences in tissue NE handling between HF and sham-operated rats. These data support the hypothesis that centrally mediated events underlie sympathetic activation of selected tissues in chronic HF.

The validity of these observations is dependent on the sensitivity of the technique to measure NE turnover and the reliability of this parameter as an indicator of noradrenergic function (5, 31, 39). The "synthesis inhibition" or AMPT method of measuring NE turnover has been validated by comparison with other turnover methods (5). A linear decline in log[NE] is evident in a variety of tissues for at least 8 h after inhibition of NE synthesis (5, 31). The rate constant kNE , which is independent of tissue NE content, can be viewed as a functional index of mean neuronal activity. NE turnover has been shown to change in direct relation to the frequency of electrical stimulation of sympathetic nerves (5, 39). Neurogenic activation by baroreceptor deafferentation increases NE turnover in various peripheral tissues (31), whereas ganglionic blockade reduces NE turnover to a level innate to each individual tissue. These observations indicate a major dependency of NE turnover on neural input from the central nervous system. The innate decline in tissue [NE] after synthesis inhibition and ganglionic blockade reflects the rate of spontaneous leakage of NE from storage vesicles and subsequent metabolism.

There is considerable evidence indicating sympathetic dysfunction in the hearts of humans with HF, as well as in animals with experimentally induced cardiac disease. Decreases in tissue [NE] and NE storage capacity are evident in enlarged hearts, whereas cardiac NE turnover has been reported to be unaltered or slightly increased in pressure overload hypertrophy (6, 17). Failing hearts do not respond adequately to sympathetic nerve stimulation (9) and are reported to have diminished levels of tyrosine hydroxylase (37), the rate-limiting enzyme for NE biosynthesis. Both NE content and turnover are high in failing hearts of rats with streptozotocin-induced diabetes mellitus (19). Cardiac NE turnover is increased in cardiomyopathic hamsters (41), although turnover normalized for heart weight is unaltered; however, no measurements of NE turnover have been reported for rats with HF induced by coronary artery ligation. The present study restricted its assessment of cardiac NE turnover to tissue from the relatively healthy apical portion of the heart, specifically, ventricular muscle not directly influenced by the infarct. Although the results failed to indicate an effect of HF on basal [NE] in this region of the heart, there was an accelerated rate of NE disappearance that was largely responsible for an increase in NE turnover. Consistent with these observations, clinical studies of regional NE kinetics have indicated an increased cardiac NE spillover in humans with HF (13, 29). Eisenhofer et al. (13) showed that increased neuronal release of NE and decreased efficiency of NE uptake both contribute to increased cardiac turnover of NE in humans with congestive HF. Furthermore, they reported that decreased NE stores in the failing human heart result from chronically increased NE turnover and reduced efficiency of NE reuptake and storage, rather than insufficient tyrosine hydroxylation (13). The increase in NE turnover may contribute to diminished myocardial beta -adrenergic receptor expression in patients with congestive HF (4), as these receptors are downregulated by prolonged agonist exposure.

Few tissues other than the heart have been evaluated for NE turnover in experimental models of congestive HF. Similar to the effect on cardiac NE handling, the results of the present study indicate that both the rate of NE disappearance and the calculated NE turnover were increased in skeletal muscle and kidney of rats with HF. NE turnover was also increased in the duodenum of HF rats, reflecting the tendency of both the rate constant and basal [NE] to be elevated in these animals. In contrast, there was no effect of HF on basal [NE], its rate of disappearance, or NE turnover in the liver and spleen. Consistent with these results, splenic NE turnover has been reported to be normal in the cardiomyopathic hamster (41). These observations provide strong evidence for a regionally heterogeneous pattern of sympathetic activation that appears to be targeted to specific tissues in experimental HF. Increased NE spillover from heart and kidney (but not liver; Refs. 13 and 22) and increased burst number in postganglionic sympathetic efferents to the vasculature of skeletal muscle (16) have been described in clinical HF. The close parallel between the results of the present study and the clinical literature strengthens the contention that sympathetic activation of some (but not all) tissues accompanies HF and indicates that coronary artery ligation in the rat represents an appropriate experimental model for studying sympathoexcitation in HF.

The results of the present study have intriguing implications regarding the impact of HF on renal function. Numerous observations suggest that sympathetic dysfunction contributes to the salt and water retention in HF. For example, acute volume expansion evokes diuresis and natriuresis associated with a reduction in renal sympathetic nerve activity (renal sympathoinhibition) (2). The renal excretory and sympathoinhibition responses to acute volume expansion are blunted in rats with HF (11), and renal denervation has been shown to normalize the excretory response (25, 34). Other evidence obtained using renal denervation or pharmacological inhibition of renal nerves also suggests an exaggerated effect of renal nerves during HF (11, 25, 34). One possibility is that there is increased basal renal sympathetic nerve activity in rats with HF. Because it is difficult to make chronic electrophysiological recordings in conscious rats, a few studies have attempted to examine this issue by recording renal nerve activity in normal and HF rats 6-8 h after surgical implantation of recording electrodes (10, 27). These results suggest increased postganglionic integrated voltage of efferent renal sympathetic nerve activity in rats with chronic congestive HF (10, 27). Others have evaluated cycle activity from multifiber recordings to provide evidence indicative of increased basal renal sympathetic nerve activity in HF rats (15). Our observation of increased renal NE turnover in conscious rats with HF provides further evidence for elevated renal sympathetic nerve activity under these conditions. Consistent with this observation, clinical studies of regional NE kinetics have indicated that renal NE spillover is increased in HF (22). It is also of interest to note that the increase in renal NE turnover was evident in the cortex, but not in the medulla. Thus the regional heterogeneity of HF-induced alterations in NE turnover is evident both between various organs and within specific organs. The intrarenal heterogeneity in NE turnover responses to HF can be expected to impact on specific aspects of renal function that are known to be under the influence of adrenergic mechanisms in the cortex. It is well known that adrenergic influences on the renal cortex promote vasoconstriction, renin release, and reabsorption of sodium and water by the proximal tubules (11, 21). Consistent with our observation of increased NE turnover in the renal cortex, rats with HF display sodium and water retention as well as increased plasma renin activity (11, 25, 34). On the basis of this reasoning, it seems reasonable to infer that increased sympathetic activation targeted to the renal cortex likely contributes to the alterations in renal function commonly observed in HF (11).

Because NE turnover is dependent in part on neural input from the central nervous system, the effect of HF to increase NE turnover in specific tissues suggests a regional heterogeneity in sympathetic neural activation mediated by central mechanisms. However, NE turnover can be influenced by any event that affects synthesis, release, uptake, or breakdown of NE at the noradrenergic nerve terminal. For example, increased circulating or local ANG II levels in HF could stimulate NE release from peripheral sympathetic nerve endings (7, 12), thus promoting increased NE turnover. Because ganglionic blockade (hexamethonium) ameliorated differences in NE handling between the sham-operated and HF rats in all tissues examined, it is unlikely that the observed increase in NE turnover involves altered intraneural metabolism of NE that leaks from storage vesicles. Thus noradrenergic processes at the level of nerve terminal that are independent of neural activity appear to be unaltered in rats with HF, which strongly implicates centrally mediated neural mechanisms in causing the regional increases in NE turnover revealed by the present study. Consistent with these studies, the rate constant of NE turnover was substantially increased in failing human heart and most of the increase was attributed to increased release of NE (13).

The effect of HF to differentially influence NE turnover in specific tissues is interesting in light of the nonuniform distribution of sympathetic activity to various peripheral vascular beds during activation of baroreceptor reflexes (24), which are known to be altered in HF (43). Indeed, HF impairs a variety of autonomic reflexes that traverse the central nervous system (30). Studies in both animals and humans have suggested that impairment of cardiopulmonary and arterial baroreflex sensory mechanisms may be important in the sympathoexcitation in chronic HF. However, sinoaortic denervation does not completely abolish the increased sympathoexcitation or elevated plasma [NE] observed in dogs with pacing-induced HF, suggesting that central mechanisms engender these events (3). Central dysfunction has also been implicated on the basis of studies demonstrating altered neural activity (35, 42) and altered noradrenergic activity in various central sites in rats with HF (40) as well as activation of central sites in doxorubicin-induced congestive cardiomyopathic rabbits (1). Consistent with these observations, recent evidence indicates that release of central nervous system monoaminergic neuronal transmitters is increased in clinical HF and that the degree of activation of aminergic brain neurons is linked to the magnitude of peripheral sympathetic activation (26). We have shown that experimental HF is associated with alterations in hexokinase activity (a marker of neuronal activity) in regions of the hypothalamus that contain vasopressin-producing neurons, as well as in sympathoexcitatory sites such as the paraventricular nucleus and the locus ceruleus (35, 42). In view of these observations, we postulate that increased neuronal activity in these central sites known to be involved in regulation of autonomic outflow may contribute to the increased sympathoexcitation observed with HF (30, 32, 35, 42).

In summary, NE turnover is elevated in specific peripheral organs of conscious undisturbed rats with HF. This observation indicates that HF provokes increased basal sympathetic activation of muscle (both cardiac and skeletal) and kidney (cortex, but not medulla), whereas liver and spleen were unaffected. The ability of ganglionic blockade to abrogate HF-induced disparities in tissue NE handling fuels the contention that the central nervous system engenders this phenomenon. Thus, although centrally mediated sympathetic activation accompanies chronic HF in the rat, the effect demonstrates a regional heterogeneity (between and within organs) that likely contributes to the functional consequences of this pathophysiological state.


    ACKNOWLEDGEMENTS

Patrick Fuller and Peggy Mazzeo provided valuable technical assistance.


    FOOTNOTES

This work was supported by grants from the National Heart, Lung, and Blood Institute (HL-48023 and HL-6222) and the American Heart Association (96006840).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: K. P. Patel, Dept. of Physiology & Biophysics, 984575 Nebraska Medical Center, Omaha, NE 68198-4575 (E-mail: kpatel{at}unmc.edu).

Received 12 April 1999; accepted in final form 27 September 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Akama, H., B. P. McGrath, and E. Badoer. Volume expansion fails to normally activate neural pathways in the brain of conscious rabbits with heart failure. J. Auton. Nerv. Syst. 73: 54-62, 1998[ISI][Medline].

2.   Badoer, E., V. Moguilevski, and B. P. McGrath. Cardiac afferents play the dominant role in renal nerve inhibition elicited by volume expansion in the rabbit. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 274: R383-R388, 1998[Abstract/Free Full Text].

3.   Brändle, M., K. P. Patel, W. Wang, and I. H. Zucker. Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs. J. Appl. Physiol. 81: 1855-1862, 1996[Abstract/Free Full Text].

4.   Bristow, M. R., R. Ginsburg, W. Minobe, R. S. Cubicciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson. Decreased catecholamine sensitivity and beta -adrenergic receptor density in failing human hearts. N. Engl. J. Med. 307: 205-211, 1982[Abstract].

5.   Brodie, B. B., E. Costa, A. Dlabac, N. H. Neff, and H. H. Smookler. Application of steady state kinetics to the estimations of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154: 493-498, 1966[Abstract/Free Full Text].

6.   Chidsey, C. A., and E. Braunwald. Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol. Rev. 18: 685-700, 1966[Abstract/Free Full Text].

7.   Clemson, B., L. Gaul, S. S. Gubin, D. M. Campsey, J. McConville, J. Nussberger, and R. Zelis. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J. Clin. Invest. 93: 684-691, 1994.

8.   Cohn, J. N., T. B. Levine, M. T. Olivari, V. Garberg, D. Lura, G. S. Francis, A. B. Simon, and T. Rector. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311: 819-823, 1984[Abstract].

9.   Covell, J. W., C. A. Chidsey, and E. Braunwald. Reduction of the cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure. Circ. Res. 19: 51-56, 1966[Abstract/Free Full Text].

10.   DiBona, G. F., S. Y. Jones, and V. L. Brooks. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 269: R1189-R1196, 1995[Abstract/Free Full Text].

11.   DiBona, G. F., and U. C. Kopp. Neural control of renal function. Physiol. Rev. 77: 75-197, 1997[Abstract/Free Full Text].

12.   Driessen, B., and K. Starke. Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 350: 618-625, 1994[ISI][Medline].

13.   Eisenhofer, G., P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996[Abstract/Free Full Text].

14.   Esler, M., G. Jennings, G. Lambert, I. Meredith, M. Horne, and G. Eisenhofer. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 70: 963-985, 1990[Free Full Text].

15.   Feng, Q. P., S. Carlsson, P. Thoren, and T. Hedner. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol. Scand. 150: 259-266, 1994[ISI][Medline].

16.   Ferguson, D. W., W. J. Berg, and J. S. Sanders. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J. Am. Coll. Cardiol. 16: 1125-1134, 1990[Abstract].

17.   Fischer, J. E., W. D. Horst, and I. J. Kopin. Norepinephrine metabolism in hypertrophied rat hearts. Nature 207: 951-953, 1965[Medline].

18.   Fishbein, M. C., D. Maclean, and P. R. Maroko. Experimental myocardial infarction in the rat. Qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 90: 57-70, 1978[Abstract].

19.   Ganguly, P. K., K. S. Dhalla, I. R. Innes, R. E. Beamish, and N. S. Dhalla. Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ. Res. 59: 684-693, 1986[Abstract/Free Full Text].

20.   Goldstein, A. Biostatistics: An Introductory Text. New York: Macmillan, 1964.

21.   Gottschalk, C. W. Renal nerve and sodium excretion. Annu. Rev. Physiol. 41: 229-240, 1979[ISI][Medline].

22.   Hasking, G. J., M. D. Esler, G. L. Jennings, D. Burton, and P. I. Korner. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity. Circulation 73: 615-621, 1986[Abstract/Free Full Text].

23.   Hopp, F. A., J. L. Seagard, and J. P. Kampine. Comparison of four methods of averaging nerve activity. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 251: R700-R711, 1986[Abstract/Free Full Text].

24.   Kirchheim, H. R. Systemic arterial baroreceptor reflexes. Physiol. Rev. 56: 100-176, 1976[Free Full Text].

25.   Kon, V., A. Yared, and I. Ichikawa. Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive HF and acute extracellular fluid volume depletion. J. Clin. Invest. 76: 1913-1920, 1985.

26.   Lambert, G. W., D. M. Kaye, J. Lefkovits, G. L. Jennings, A. G. Turner, H. S. Cox, and M. D. Esler. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 92: 1813-1818, 1995[Abstract/Free Full Text].

27.   Leenen, F. H. H., B. S. Huang, H. L. Yu, and B. X. Yuan. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ. Res. 77: 993-1000, 1995[Abstract/Free Full Text].

28.   Leimbach, W. N., B. Gunner Wallin, R. G. Victor, P. E. Aylward, G. Sundlof, and A. L. Mark. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919, 1986[Abstract/Free Full Text].

29.   Meredith, I. T., G. Eisenhofer, G. W. Lambert, E. M. Dewar, G. L. Jennings, and M. D. Esler. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136-145, 1993[Abstract/Free Full Text].

30.   Patel, K. P. Neural regulation in experimental heart failure. Bailliere's Clin. Neurol. 6: 283-296, 1997[Medline].

31.   Patel, K. P., J. Ciriello, and R. L. Kline. Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection. Am. J. Physiol. Heart Circ. Physiol. 240: H481-H486, 1981.

32.   Patel, K. P., and K. Zhang. Neurohumoral activation in heart failure: role of paraventricular nucleus. Clin. Exp. Pharmacol. Physiol. 23: 722-726, 1996[ISI][Medline].

33.   Patel, K. P., K. Zhang, I. H. Zucker, and T. L. Krukoff. Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure. Brain Res. 734: 109-115, 1996[ISI][Medline].

34.   Patel, K. P., P. L. Zhang, and P. K. Carmines. Neural influences on renal responses to acute volume expansion in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 271: H1441-H1448, 1996[Abstract/Free Full Text].

35.   Patel, K. P., P. L. Zhang, and T. L. Krukoff. Alterations in brain hexokinase activity associated with heart failure in rats. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 265: R923-R928, 1993[Abstract/Free Full Text].

36.   Pfeffer, M. A., J. M. Pfeffer, M. C. Fishbein, P. J. Fletcher, J. Spadaro, R. A. Kloner, and E. Braunwald. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979[Abstract/Free Full Text].

37.   Pool, P. E., J. W. Covell, M. Levitt, J. Gibb, and E. Braunwald. Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Circ. Res. 20: 349-353, 1967[Abstract/Free Full Text].

38.   Rundqvist, B., M. Elam, Y. Bergmann-Sverrisdottir, G. Eisenhofer, and P. Friberg. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95: 169-175, 1997[Abstract/Free Full Text].

39.   Sharman, D. F. The turnover of catecholamines. In: Central Neurotransmitter Turnover, edited by C. J. Pycock, and P. V. Taberner. London: Oxford, 1981, p. 20-58.

40.   Sole, M. J., M. N. Hussain, D. H. G. Versteeg, E. R Ronald de Kloet, D. Adams, and W. Lixfeld. The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial ischemia in the rat. Brain Res. 235: 315-325, 1982[ISI][Medline].

41.   Sole, M. J., C.-M. Lo, C. W. Laird, E. H. Sonnenblick, and R. J. Wurtman. Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ. Res. 37: 855-862, 1975[Abstract/Free Full Text].

42.   Vahid-Ansari, F., and F. H. H. Leenen. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 275: H2140-H2146, 1998[Abstract/Free Full Text].

43.   Zucker, I. H., W. Wang, M. Brändle, H. D. Schultz, and K. P. Patel. Neural regulation of sympathetic nerve activity in heart failure. Prog. Cardiovasc. Dis. 37: 397-414, 1995[ISI][Medline].


Am J Physiol Regul Integr Compar Physiol 278(3):R556-R562
0363-6119/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. C. Kleiber, H. Zheng, H. D. Schultz, J. D. Peuler, and K. P. Patel
Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1863 - R1872.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Zheng, Y.-F. Li, I. H. Zucker, and K. P. Patel
Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1148 - F1156.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
{beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, and L. A. Smith
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R116 - R124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. E. Lohmeier
Neurohumoral regulation of arterial pressure in hemorrhage and heart failure
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R810 - R814.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Zhang, Y.-F. Li, and K. P. Patel
Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1006 - R1015.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Zhang, Y.-F. Li, and K. P. Patel
Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H995 - H1004.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, K. P.
Right arrow Articles by Carmines, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, K. P.
Right arrow Articles by Carmines, P. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online